Related Topics:
Facility ID: 01432PHRMC25PAT
Facility Name and Address: VERANOVA L.P. 25 PATTON RD DEVENS, MA 01434 Parent Company: VERANOVA BIDCO L.P. Industry: Pharmaceutical Preparation Manufacturing (325412) Chemical: Methyl isobutyl ketone Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000108101
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2018 |
Source Reduction - The use of first pass distillates for further processing and for emptying the column was introduced by production coordinators and project managers but this process must receive approval from client representatives before proceeding. Source Reduction: Source Reduction - When possible first pass distillates are returned to the chromatography process and this reduces the need to add new solvents into the process. This reduces the need for adding new solvents to the column. |
||
2017 |
Other Barriers to Source Reduction - JM IS A CONTRACT PHARMACEUTICAL MANUFACTURING AND RESEARCH FIRM WHICH MANUFACTURES PRODUCTS ON A BATCH BASIS BY CLIENT. THE CLIENTS PROJECTS DICTATE THE CHEMICALS USED AND THE QUANTITIES. AS THESE PRODUCTS MAY BE IN FDA APPROVAL PROCESS OR ALREADY FDA APPROVED JM HAS LITTLE OPPORTUNITY TO ENCOURAGE LESS HAZARDOUS CHEMICAL SUBSTITUTIONS. WHEN POSSIBLE IN EARLY STAGES OF WORKING WITH NEW CLIENT, JM WILL OFFER TO OPTIMIZE PROCESS WHICH MAY RESULT IN LESS CHEMICALS USED OVERALL BY REDUCING NUMBER OF FILTRATIONS, WASHES, ETC. Other Environmental Practices: Energy Recovery - JM encourages waste vendors to seek energy recovery opportunities whenever possible. |
||
2016 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - JM is a pharmaceutical contract manufacturing company which manufactures active pharmaceutical ingredients and intermediates based on clients' projects. This is a batch run manufacturing operation and therefore amounts of chemicals and chemicals used are dependent on the clients' projects and what those projects require. |
|
2015 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - The facility used MIBK in 2015 for column chromatography related to purification process for a client specific project. The chromatography process relies on specific solvents which are used based on the client's requirements and the solvent properties which will help purify the materials. Additionally the facility manufactured the client's subunits due to production issues at another facility. This resulted in additional MIBK used in 2015. |